Cervical cancer screening in Europe: Quality assurance and organisation of programmes

• Published in: European journal of cancer (1990) 2015-05, Vol.51 (8), p.950-968
• Main Authors: Elfström, K. Miriam, Arnheim-Dahlström, Lisen, von Karsa, Lawrence, Dillner, Joakim
• Format: Article
• Language: English
• Subjects: Adult; Aged; Alphapapillomavirus - isolation & purification; Cervical cancer screening; Cost-Benefit Analysis; Early Detection of Cancer - economics; Early Detection of Cancer - methods; Early Detection of Cancer - standards; Europe - epidemiology; Female; Guidelines; Health policy; Hematology, Oncology and Palliative Medicine; Humans; Mass Screening - economics; Mass Screening - organization & administration; Mass Screening - standards; Medicin och hälsovetenskap; Middle Aged; Practice Guidelines as Topic - standards; Prevention; Quality assurance; Quality Assurance, Health Care - economics; Quality Assurance, Health Care - organization & administration; Surveys and Questionnaires; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - epidemiology; Young Adult
• ISSN: 0959-8049; 1879-0852; 1879-0852
• DOI: 10.1016/j.ejca.2015.03.008

Abstract Background Cervical screening programmes have reduced cervical cancer incidence and mortality but the level of success is highly variable between countries. Organisation of programmes is essential for equity and cost-effectiveness. However, there are differences in effectiveness, also among organised programmes. In order to identify the key organisational components that determine effectiveness, we performed a Europe-wide survey on the current status of organisation and organised quality assurance (QA) measures in cervical cancer prevention programmes, as well as organisation-associated costs. Methods A comprehensive questionnaire was developed through systematic review of literature and existing guidelines. The survey was sent to programme organisers, Ministries of Health and experts in 34 European Union (EU) and European Free Trade Agreement (EFTA) countries. Detailed aspects of programme organisation, quality assurance, monitoring, evaluation and corresponding line-item costs were recorded. Documentation of programme guidelines, protocols and publications was requested. Results Twenty-nine of 34 countries responded. The results showed that organised efforts for QA, monitoring and evaluation were carried out to a differing extent and were not standardised, making it difficult to compare the cost-effectiveness of organisation and QA strategies. Most countries found it hard to estimate the costs associated with launching and operating the organised programme. Conclusions To our knowledge, this is the first questionnaire to request detailed information on the actual organisation and QA of programmes. The results of this survey can be used as a basis for further development of standardised guidelines on organisation and QA of cervical cancer screening programmes in Europe.